Prominent Cardiologist Dr. Jason Zagrodzky Joins Cardi/o® Advisory Board
Cardi/o® is pleased to announce the addition of Dr. Jason Zagrodzky to its Advisory Board. Dr. Zagrodzky is a doctor of cardiology at Texas Cardiac Arrythmia Institute (TCAI), a division of St. David’s Medical Center, and home to a state-of-the-art Electrophysiology Center dedicated to treating patients with cardiac arrhythmias. Dr. Zagrodzky is among the world-renowned electrophysiologists at TCAI who are committed to providing the highest level of care for patients with cardiac arrhythmias with the latest advances in interventional cardiac electrophysiology to improve outcomes for patients worldwide. His training and expertise offer a fine understanding of human cardiology as it pertains to users of the company’s Cardi/o® touchless cardiac monitor.
In addition to his clinical cardiac electrophysiology expertise, Dr. Zagrodzky’s regulatory work include serving as Principal Investigator on a 12-month FDA Clinical Trial sponsored by Abbot Medical Devices. His contributions to science include the treatment of the first premature ventricular contraction case using a new cardiac mapping system to treat heart arrythmias at St. David’s Medical Center. He was a participant in the largest device study to-date designed to evaluate the performance of Attune Medical’s ensoETM patient temperature management device as an aid in the reduction of esophageal injury during cardiac ablation. As a past president of the Alpha Omega Alpha National Honor Medical Society and recipient of the prestigious Mayes-Smith Award in Internal Medicine, Dr. Zagrodzky is recognized for academic excellence and compassion for patients.
“We’re pleased to have Jason join our team,” says CEO Sajol Ghoshal. “His intricate knowledge of cardiac electrophysiology and championing of technologies that can improve patient treatment signals the tremendous responsibility we possess as pioneers in remote, touchless cardiac monitoring. With Jason’s guidance and passion, Cardi/o® will usher in adoptable telehealth practices in a post-COVID19 world.”
“’Adoptable’ is the operative word, “ explains Stephanie Probasco, Director of Marketing. “We know that people age 65yrs+ tend to reject wearables for everyday use. By removing the wearable element, we make cardiac health monitoring at home exceptionally easy and convenient, therefore, more adoptable for everyday use, which is really what sets us apart, and I believe Dr. Zagrodzky also recognizes the impact this can have to advance health at home.”
Dr. Zagrodzky completed his Fellowship in Clinical Cardiac Electrophysiology at the University of Texas Southwestern Medical School, Dallas, TX and currently practices at Texas Cardiac Arrhythmia Institute, St. David’s Medical Center in Austin, TX. He has Over 30 publications and presentations in medical journals covering cardiology topics, including The New England Journal of Medicine.